Your browser does not support the video tag.
Skip to content
home button
  • Resources
    • By Topic
      • Access to Clinical Trials
      • Artificial Intelligence
      • Clinical Trials Landscape
      • Data Collecting + Reporting
      • Ensuring Quality
      • Innovative Trials
      • Patient Engagement
      • Recruitment
      • Regulatory Submissions + Approvals
      • Safety
      • Site Planning
    • By Trial Stage
      • Study Design
        • Innovative Trials
        • Patient Group Engagement
        • Recruitment
      • Study Operations
        • Data Collecting
        • Regulatory Submissions + Approvals
        • Site Planning
  • Case Studies
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
connect with us
Signup for our Newsletter
  • About CTTI
  • Newsroom
  • Membership
  • Annual Report
Search

CTTI

Clinical Trials Transformation Initiative

Publications

Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative

Posted on February 21, 2018February 10, 2025 by Hannah Faulkner

Clinical trials recruitment planning: A proposed framework from the Clinical Trials Transformation Initiative

Posted in Ensuring Quality, Publications, Recruitment, Recruitment, Recruitment, Related: Recruitment, Study Design, Study Operations

Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature Review

Posted on February 21, 2018February 4, 2025 by Hannah Faulkner

Use of Mobile Devices to Measure Outcomes in Clinical Research, 2010–2016: A Systematic Literature Review

Posted in Developing Novel Endpoints, Innovative Trials, Novel Endpoints, Publications, Regulatory Submissions + Approvals, Related: Developing Novel Endpoints, Study Design, Study Operations

The Clinical Trials Transformation Initiative. One Decade of Impact. One Vision Ahead.

Posted on February 16, 2018March 31, 2025 by Hannah Faulkner

The Clinical Trials Transformation Initiative. One Decade of Impact. One Vision Ahead.

Posted in Publications

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach

Posted on February 8, 2018October 7, 2024 by Hannah Faulkner

Advancing Pediatric Antibacterial Drug Development: A Critical Need to Reinvent our Approach

Posted in ABDD Peds Trials, Antibacterial Drug Development-Peds Trials, Publications, Related: ABDD Peds Trials

Perceived Barriers to Pediatrician and Family Practitioner Participation in Pediatric Clinical Trials: Findings from the Clinical Trials Transformation Initiative

Posted on December 10, 2017October 7, 2024 by Hannah Faulkner

Perceived Barriers to Pediatrician and Family Practitioner Participation in Pediatric Clinical Trials: Findings from the Clinical Trials Transformation Initiative

Posted in ABDD Peds Trials, Antibacterial Drug Development-Peds Trials, Publications, Related: ABDD Peds Trials

Parents’ perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative

Posted on December 10, 2017October 7, 2024 by Hannah Faulkner

Parents’ perceived obstacles to pediatric clinical trial participation: Findings from the clinical trials transformation initiative

Posted in ABDD Peds Trials, Antibacterial Drug Development-Peds Trials, Publications, Related: ABDD Peds Trials

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial

Posted on August 17, 2017October 4, 2024 by Hannah Faulkner

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial 

Posted in ABDD HABP/VABP, Antibacterial Drug Development-HABP/VABP Studies, Publications, Related: ABDD HABP/VABP

The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials

Posted on August 1, 2017February 7, 2025 by Hannah Faulkner

The Rules of Engagement: CTTI Recommendations for Successful Collaborations Between Sponsors and Patient Groups Around Clinical Trials

Posted in Patient Engagement, Patient Group Engagement, Patient Group Engagement, Publications, Related: Patient Group Engagement, Study Design

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative

Posted on May 13, 2017January 31, 2025 by Hannah Faulkner

Recommendations for data monitoring committees from the Clinical Trials Transformation Initiative

Posted in Completed, Data Monitoring Committees, Data Monitoring Committees, Ensuring Quality, Publications, Related: Data Monitoring Committees, Safety, Study Operations

Sponsors’ and investigative staffs’ perceptions of the current investigational new drug safety reporting process in oncology trials

Posted on March 26, 2017February 11, 2025 by Hannah Faulkner

Sponsors’ and investigative staffs’ perceptions of the current investigational new drug safety reporting process in oncology trials

Posted in Publications, Related: Safety Reporting, SAE Reporting, Safety, Safety Reporting, Study Operations

Posts navigation

← Older posts
Newer posts →
 

DISCLAIMER: CTTI encourages the use of all materials listed on this site in the pursuit of improving the clinical trials enterprise. Our recommendations, tools, meeting summaries, and more are available to the public for free. We do ask that you acknowledge the source whenever using or referencing CTTI materials. Read our Citation Policy. 

  • About
  • Newsroom
  • Membership
  • Case Studies
  • Contact Us
  • Access to Clinical Trials
  • Artificial Intelligence
  • Clinical Trials Landscape
  • Data Collecting + Reporting
  • Ensuring Quality
  • Innovative Trials
  • Informed Consent
  • Patient Group Engagement
  • Real-World Data
  • Recruitment
  • Regulatory Submissions + Approvals
  • Safety + Protection
  • Site Planning
Sign up for our Newsletter
Log in

© Clinical Trials Transformation Initiative © 2026

terms of use

privacy statement

WordPress is a content management system and should not be used to upload any PHI as it is not an environment for which we exercise oversight, meaning you the author are responsible for the content you post. Please use this system accordingly.